SEROTYPES
The 4 dengue serotypes are circulating in the region, sometimes with a hyperendemic pattern (cocirculation of 2 or more serotypes). In 2013, the countries reporting the cocirculation of all serotypes were as follows: Mexico, Guatemala, Nicaragua, Colombia, Venezuela, French Guiana, Guadeloupe, Martinique, Brazil, Peru, and Argentina [2] .
REPORTED CASES: OUTBREAKS
In 2013, record figures of more than 2 million dengue cases were reported by countries to PAHO, 32 270 of them were considered to be severe, the incidence rate was of 404.35 per 100 000 population, and there were 1175 deaths and a case fatality rate of 0.05. In Brazil, there more than 1 million cases were reported, more than the total cases reported in the whole region in 2012 (Supplementary Figure 1) .
In the last 15 years, Brazil, Mexico, Colombia, and Venezuela have had the most important outbreaks in Latin America in terms of number of cases (Supplementary Figure 2) . In 2013, 4 countries (Brazil, Mexico, Colombia, and Paraguay) had outbreaks, reporting the 83% of total dengue cases of that year [3] .
SEASONALITY
Epidemic patterns of 3-5 years have been observed, with an increasing number of reported cases in the last 5 years. Cases have been reported with a seasonality pattern related to rainy season in most of countries. Countries such as Mexico and Honduras have cases mostly reported in the second half of the year, whereas Brazil, Peru, and Paraguay report cases mostly in the first half of the year. Colombia and Venezuela report cases during the whole year, with an increase of cases at rainy season [2, [4] [5] [6] .
AGE DISTRIBUTION
There is a trend of severe cases in younger ages in the last 10 years in Latin America, compared with what had been observed previously (most frequent in young adults). For example, the highest incidence of cases in Venezuela in 2013 (>400 per 100 000 inhabitants) were reported in children <15 years old, including children <1 years old [7] . In Mexico, the dengue incidence for dengue and dengue severe is higher in people between 10 and 19 years old [2, 8] .
ETIOLOGY
Some macro-determinant factors may contribute to the increasing dengue cases, such as the following: unprecedented population growth, unplanned and uncontrolled urbanization, poverty, population movement (migration, tourism), and climatic change.
CONTROL MEASUREMENTS: INTEGRATED MANAGEMENT STRATEGY
Countries continue with efforts for disease control through specific actions against Aedes mosquitoes and PAHO's Integrated Management Strategy for dengue prevention and control. This strategy is a management model designed to strengthen national strategy, with a focus on reducing morbidity, mortality, and the societal and economic burden produced by outbreaks and epidemics. The main axis of action are as follows: (1) (6) social communication, for the behavioral impact, eg, videos available via internet and addressed to children and adolescents (video game Pueblo Pitanga, available at www.pueblopitanga.com). This strategy has been implemented in 27 countries and territories of the Americas and has been evaluated in 22 countries. In addition, complementary measures such as a future dengue vaccine could represent an additional tool for Integrated Management Strategy for dengue prevention and control [9] .
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